ASHLEY OZBIRN: Open Payments
NPI 1093054595 · HAMILTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 37 payments from 5 companies in 2025. Trend: 2023 $335 · 2024 $370 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $253 |
| Novo Nordisk Inc | 3 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Amgen Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $14 |
Products named: UBRELVY, VRAYLAR, Wegovy, QULIPTA, TRULANCE, OTEZLA, REXULTI.
Industry payments across AL — which companies pay providers there.
